Author:
Lemieux Mackenzie,Telles Rachel,Goodheart Michael,Dahmoush Laila,Hagemann Ian,Penedo Frank J.,Nandakumar Renu,Cole Steve W.,Sood Anil K.,Lutgendorf Susan K.,Thaker Premal H.
Funder
American Cancer Society
Sveriges Kommuner och Landsting
NIH Library
Reference44 articles.
1. Ovarian cancer statistics, 2018;Torre;CA Cancer J. Clin.,2018
2. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems;Vang;Adv Anat Pathol,2009
3. Grading ovarian serous carcinoma using a two-tier system;Malpica;Am. J. Surg. Pathol.,2004
4. Molecular typing of epithelial ovarian carcinomas using inflammatory markers;Ali-Fehmi;Cancer,2011
5. MILO/ENGOT-ov11: Binimetinib versus Physician's choice chemotherapy in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum;Monk;J. Clin. Oncol.,2020